Market Overview

35 Stocks Moving in Wednesday's Pre-Market Session

Share:
35 Stocks Moving in Wednesday's Pre-Market Session

Gainers

  • Medalist Diversified REIT, Inc. (NASDAQ: MDRR) rose 138.3% to $2.74 in pre-market trading. Medalist Diversified REIT announced a dividend for the third quarter on its 8.0% Series A Cumulative Redeemable Preferred Stock in the amount of $0.5000 per share.
  • Gulfport Energy Corporation (NASDAQ: GPOR) rose 50.5% to $0.5402 in pre-market trading after dropping around 30% on Tuesday.
  • Genesis Healthcare, Inc. (NYSE: GEN) rose 45.9% to $0.7648 in pre-market trading after the company reported its subsidiary LTC ACO received positive reconciliation and settlement under the Medicare Shared Savings Program.
  • Allscripts Healthcare Solutions, Inc. (NASDAQ: MDRX) shares rose 37.2% to $11.40 in pre-market trading after the company agreed to sell its CarePort Health business to WellSky for $1.35 billion.
  • Taiwan Liposome Company, Ltd. (NYSE: TLC) shares rose 35.4% to $6.24 in pre-market trading as the company disclosed that it has enrolled first subject in Phase I clinical trial of inhalable anti-COVID-19 program.
  • Humanigen, Inc. (NASDAQ: HGEN) rose 29.7% to $15.60 in pre-market trading. HC Wainwright & Co. initiated coverage on Humanigen with a Buy rating and announced a price target of $31.
  • Capital Senior Living Corporation (NYSE: CSU) rose 28% to $0.7899 in pre-market trading. Capital Senior Living reported CFO transition last month.
  • Theratechnologies Inc. (NASDAQ: THTX) rose 19.3% to $2.72 in pre-market trading after the company confirmed the USPTO issued its patent covering the use of Tesamorelin in the treatment of individuals suffering from NAFLD/NASH.
  • VOXX International Corp (NASDAQ: VOXX) rose 19.2% to $10.30 in pre-market trading after the company swung to a profit in the second quarter.
  • Centennial Resource Development, Inc. (NASDAQ: CDEV) shares rose 18% to $0.7310 in pre-market trading as the company reported that JP Morgan Chase Bank has reaffirmed borrowing base of $700 million. The company also reported liquidity increased by 6% versus the prior quarter.
  • Concho Resources Inc (NYSE: CXO) rose 9.2% to $48.22 in pre-market trading. Bloomberg reported that Concophillips is in talks to acquire Concho.
  • NIO Limited (NYSE: NIO) rose 8.3% to $23.40 in pre-market trading. JP Morgan upgraded NIO from Neutral to Overweight and announced a $40 price target. The company’s annual Nio Day, which is customarily held in December, has been pushed back and will be held Jan. 9, 2021.
  • GameStop Corp. (NYSE: GME) shares rose 7.7% to $12.80 in pre-market trading after Richard Mashaal’s hedge fund firm, Senvest Management LLC, purchased over 3.6 million common stock representing a 5.54% stake in GameStop last week.
  • Enlivex Therapeutics Ltd. (NASDAQ: ENLV) rose 7.4% to $14.89 in pre-market trading after surging over 22% on Tuesday. Enlivex Therapeutics recently issued positive news related to the company's COVID-19 treatment.
  • Heat Biologics, Inc. (NASDAQ: HTBX) rose 6.1% to $1.39 in pre-market trading. Heat Biologics, last week, announced that it issued an additional patent on its Gp96 Combination platform for its therapy with T-Cell Co-Stimulator.
  • Ocean Power Technologies, Inc. (NASDAQ: OPTT) shares rose 6.1% to $2.44 in pre-market trading following a 5% gain on Tuesday.
  • Bed Bath & Beyond Inc. (NASDAQ: BBBY) rose 5.4% to $23.35 in pre-market trading after the company announced plans to sell its non-core assets.
  • Grubhub Inc. (NYSE: GRUB) rose 4.3% to $79.01 in pre-market trading. Shareholders of Just Eat Takeaway.com NV recently approved a proposed acquisition of GrubHub.
  • Onconova Therapeutics, Inc. (NASDAQ: ONTX) rose 4.1% to $0.35 in pre-market trading after climbing over 24% on Tuesday. Onconova Therapeutics, last month, announced initiation of Phase 1 clinical trial of ON 123300 in China by partner HanX Biopharmaceuticals.
  • Hyliion Holdings Corp. (NYSE: HYLN) rose 3.4% to $27.39 in pre-market trading after Axioma disclosed a 10.82% active stake in the company.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Enzo Biochem, Inc. (NYSE: ENZ) fell 11.9% to $2.30 in pre-market trading after the company reported Q4.
  • Sorrento Therapeutics, Inc. (NASDAQ: SRNE) fell 11.7% to $10.55 in pre-market trading. Sorrento Therapeutics yesterday said it has entered into an exclusive license agreement with Personalized Stem Cells, Inc. to acquire global rights to its adipose-derived mesenchymal stem cells for patients suffering from acute respiratory distress syndrome-associated with COVID-19.
  • Ring Energy, Inc. (NYSE: REI) fell 11.1% to $0.6514 in pre-market trading. Ring Energy, last week, said the buyer of its Delaware Basin acreage asked for an extension to the end of October and wired an additional $1 million.
  • Alphatec Holdings Inc (NASDAQ: ATEC) fell 9.7% to $9.26 in pre-market trading after the company reported an $85 million common stock offering.
  • Ocular Therapeutix Inc (NASDAQ: OCUL) fell 8.8% to $11.05 in pre-market trading after the company priced its 7.18 million share common stock offering at $9.75 per share.
  • Blonder Tongue Laboratories, Inc. (NYSE: BDR) fell 8.7% to $1.37 in pre-market trading. Blonder Tongue shares jumped 34% on Tuesday after the company reported U.S. patent grant for its networking modules for display systems.
  • Cytokinetics, Incorporated (NASDAQ: CYTK) fell 7.8% to $15.58 in pre-market trading after gaining around 8% on Tuesday.
  • Auris Medical Holding Ltd. (NASDAQ: EARS) shares fell 7.6% to $0.9520 in pre-market trading after surging 22% on Tuesday. Bloomberg reported that Johnson & Johnson was accused in a lawsuit of deceiving investors regarding performance-based earnings from Auris Health. Traders seem to be mistaking Auris Medical for Auris Health, which was acquired by Johnson & Johnson. Auris Medical announced initiation of part B of TRAVERS Phase 2 study with AM-125 in vertigo.
  • Nxt-ID, Inc. (NASDAQ: NXTD) shares fell 7.1% to $0.37 in pre-market trading after climbing around 20% on Tuesday. Nxt-ID announced plans to adjourn the Annual Meeting of Stockholders.
  • AIkido Pharma Inc. (NASDAQ: AIKI) fell 6.5% to $0.56 in pre-market trading. AIkido Pharma, last month, received Nasdaq deficiency note related to compliance with $1 per share minimum bid price requirement.
  • iBio, Inc. (NASDAQ: IBIO) fell 6.1% to $2.10 in pre-market trading after reporting a decline in FY20 sales.
  • Vaxart, Inc. (NASDAQ: VXRT) shares fell 6.1% to $7.20 in pre-market trading. Vaxart shares jumped around 9% on Tuesday after the company announced the first subject has been dosed in its Phase 1 study of VXA-CoV2-1, an oral tablet COVID-19 vaccine candidate..
  • RAVE Restaurant Group, Inc. (NASDAQ: RAVE) fell 6% to $0.7708 in pre-market trading. RAVE Restaurant Group, recently, announced hiring of two new executives to fuel franchise development.
  • Wah Fu Education Group Limited (NASDAQ: WAFU) fell 6% to $4.44 in pre-market trading after declining over 31% on Tuesday.
  • Salem Media Group, Inc. (NASDAQ: SALM) shares fell 5% to $0.95 in pre-market trading.
 

Related Articles (ATEC + AIKI)

View Comments and Join the Discussion!

Posted-In: Premarket MoversNews Penny Stocks Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com